Memorial Sloan Kettering Cancer Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Memorial Sloan Kettering Cancer Center takes part in 32 sessions at ESMO 2026 in Madrid. Its program centres on sarcoma and gastrointestinal cancers, from T-cell therapy and KIT inhibitors in sarcoma to team-based care of rectal, gastric and pancreatic cancer. Other sessions cover artificial intelligence that combines real-world data to predict outcomes, and telling germline from tumour-only findings in sequencing results.
| Organization | ESMO 2026 Attendance |
|---|---|
Memorial Sloan Kettering Cancer Center New York, NY | |
Cancer treatment and research centre in New York City, New York. | Keynote Fri Oct 23 11:38–11:48 Talk Fri Oct 23 13:30–13:45 Abstract Fri Oct 23 14:32–14:42 Abstract Fri Oct 23 14:42–14:52 Invited Discussant 4733O and 4734O Genitourinary cancers Talk Fri Oct 23 16:15–17:15 Talk Fri Oct 23 16:35–16:55 T-cell therapy in sarcoma: A hopeful future or unreachable reality? Sarcoma, CNS, head & neck and rare cancers Satellite Fri Oct 23 19:00–19:25 Chair Sat Oct 24 08:30–10:00 Talk Sat Oct 24 09:00–09:15 Beyond immune-checkpoint inhibition Gastrointestinal cancers Abstract Sat Oct 24 09:14–09:19 Talk Sat Oct 24 09:30–09:50 Survival tactics: Adaptation mechanisms in metastatic tumors Biomarkers & precision oncology Abstract Sat Oct 24 09:32–09:44 Keynote Sat Oct 24 12:20–12:45 Chair Sat Oct 24 14:45–16:15 Proffered paper: Gynaecological cancers Gynaecological cancers Chair Sat Oct 24 14:45–16:15 Rapid oral: Gastrointestinal tumours, lower digestive Gastrointestinal cancers Abstract Sat Oct 24 14:55–15:05 3715O - A phase 1/2 trial of zolucatetide, a first-in-class direct β-catenin:TCF inhibitor: updated safety and efficacy in patients with desmoid tumors Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 15:00–15:15 Invited Discussant 787RO, 788RO and 789RO Gastrointestinal cancers Abstract Sat Oct 24 15:15–15:27 Invited Discussant 1239O, LBA36 and LBA37 Gynaecological cancers Talk Sun Oct 25 09:10–09:30 Chair Sun Oct 25 10:15–11:45 Talk Sun Oct 25 10:15–10:30 Chair Sun Oct 25 10:15–11:45 Proffered paper: Gastrointestinal tumours, lower digestive Gastrointestinal cancers Talk Sun Oct 25 10:15–10:30 Abstract Sun Oct 25 11:00–11:10 Chair Sun Oct 25 12:00–12:50 What oncologists should know about non-pharmaceutical interventions Nursing & supportive care Talk Sun Oct 25 12:30–12:45 Integrative oncology: What is the evidence? Nursing & supportive care Chair Sun Oct 25 14:45–16:00 LARC: The essential role of multidisciplinary management of locally advanced rectal cancer Gastrointestinal cancers Talk Sun Oct 25 14:45–15:05 Locally advanced gastric and gastroesophageal cancer: Perioperative therapy Gastrointestinal cancers Chair Sun Oct 25 14:45–16:25 Chair Sun Oct 25 14:45–16:15 State-of-the-art treatment for non metastatic upper GI cancers Gastrointestinal cancers Talk Sun Oct 25 15:30–15:50 Tailoring post TNT strategies based on tumour response Gastrointestinal cancers Abstract Sun Oct 25 15:35–15:45 Chair Sun Oct 25 16:30–17:15 Frontline treatment for leiomyosarcoma: What level of evidence is required for clinical implementation? Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 17:54–18:06 Invited Discussant LBA8 Lung & thoracic cancersGastrointestinal cancers Chair Mon Oct 26 08:30–10:00 Rapid oral: Sarcoma Sarcoma, CNS, head & neck and rare cancers Abstract Mon Oct 26 08:40–08:45 Abstract Mon Oct 26 09:34–09:39 3725RO - Lifileucel in Patients with Undifferentiated Pleomorphic Sarcoma (UPS) or Dedifferentiated Liposarcoma (DDLS) Sarcoma, CNS, head & neck and rare cancers Abstract Mon Oct 26 09:39–09:51 Invited Discussant 3723RO, 3724RO and 3725RO Sarcoma, CNS, head & neck and rare cancers Chair Mon Oct 26 10:15–11:45 Rapid oral 2: Breast cancer, advanced stage Breast cancer Talk Mon Oct 26 11:15–11:35 Immunotherapy in pancreatic cancer: Overcoming barriers to Success Gastrointestinal cancers Abstract Mon Oct 26 11:27–11:37 Invited Discussant 1769RO and 1770RO Breast cancer Talk Mon Oct 26 12:00–12:15 Somatic vs germline: Avoiding the most common mistakes Biomarkers & precision oncology Chair Mon Oct 26 12:00–12:50 What oncologists should know about interpreting tumour sequencing Biomarkers & precision oncology Abstract Mon Oct 26 14:45–14:55 Talk Mon Oct 26 14:50–15:10 Diagnostic and prognostic assessment Sarcoma, CNS, head & neck and rare cancers Talk Mon Oct 26 15:10–15:35 Clinical trials and regulatory landscape in tumour-agnostic oncology Biomarkers & precision oncology |
Instantly find 20 buyers from Memorial Sloan Kettering Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction